← Back to Search

Graft-Augmented Rectocele Repair-A Randomized Surgical Trial

N/A
Waitlist Available
Led By Vivian W Sung, MD MPH
Research Sponsored by Women and Infants Hospital of Rhode Island
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is to determine whether adding a graft during a rectocele repair will improve the success rate of the repair.

Eligible Conditions
  • Rectocele

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 2Experimental Treatment1 Intervention
Posterior repair with graft
Group II: 1Active Control1 Intervention
Native tissue repair
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Graft augmented posterior repair
2004
N/A
~160

Find a Location

Who is running the clinical trial?

Women and Infants Hospital of Rhode IslandLead Sponsor
114 Previous Clinical Trials
40,190 Total Patients Enrolled
Vivian W Sung, MD MPHPrincipal InvestigatorWomen and Infants Hospital
~7 spots leftby Jan 2026